SRNE logo

Sorrento Therapeutics (SRNE) Total Liabilities

Annual Total Liabilities

$494.51 M
-$122.18 M-19.81%

December 31, 2022

Summary

Performance

1-Year Change

-19.81%

3-Year Change

-5.79%

5-Year Change

+119.78%

15-Year Change

+119.78%

SRNE Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.32%
SRNE annual total liabilities is higher than 81.32% of companies in Healthcare sector

High & Low

All-time High

$616.69 M
SRNE annual total liabilities is currently -19.81% below its historical high of $616.69 million

3-Year Low

$494.51 M
SRNE annual total liabilities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
SRNE previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
SRNE next annual earnings announcement has not yet been scheduled

OtherSRNEbalance sheetmetrics:

Quarterly Current Liabilities

$264.95 M
SRNE quarterly total current liabilities is $264.95 million

Quarterly Long Term Liabilities

$389.70 M
SRNE quarterly total long term liabilities is $389.70 million

Quarterly Total Assets

$456.69 M
SRNE quarterly total assets is $456.69 million

Quarterly Current Assets

$133.11 M
SRNE quarterly total current assets is $133.11 million

Quarterly Total Liabilities

$654.65 M
+$67.17 M+11.43%

June 30, 2023

Summary

Performance

3-Month Change

+11.43%

1-Year Change

+11.43%

3-Year Change

+11.43%

5-Year Change

+11.43%

SRNE Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.76%
SRNE quarterly total liabilities is higher than 83.76% of companies in Healthcare sector

High & Low

All-time High

$654.65 M
SRNE quarterly total liabilities is currently at an all-time high

3-Year Low

$485.41 M
SRNE quarterly total liabilities is currently +34.87% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
SRNE previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
SRNE next earnings announcement has not yet been scheduled

OtherSRNEbalance sheetmetrics:

Quarterly Current Liabilities

$264.95 M
SRNE quarterly total current liabilities is $264.95 million

Quarterly Long Term Liabilities

$389.70 M
SRNE quarterly total long term liabilities is $389.70 million

Quarterly Total Assets

$456.69 M
SRNE quarterly total assets is $456.69 million

Quarterly Current Assets

$133.11 M
SRNE quarterly total current assets is $133.11 million

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

Annual Total Liabilities

$494.51 M
SRNE annual total liabilities is $494.51 million

Annual Current Liabilities

$327.92 M
SRNE annual total current liabilities is $327.92 million

Annual Total Long Term Liabilities

$166.59 M
SRNE annual total long term liabilities is $166.59 million

SRNE Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.8%+11.4%
3 y3 years-5.8%+11.4%
5 y5 years+119.8%+11.4%

SRNE Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-19.8%at lowat high+34.9%
5 y5-year-19.8%+25.2%at high+71.0%
alltimeall time-19.8%>+9999.0%at high-100.0%

Sorrento Therapeutics Total Liabilities History

DateAnnualQuarterly
Jun 2023
-
$654.65 M(+11.4%)
Mar 2023
-
$587.48 M(+18.8%)
Dec 2022
$494.51 M(-19.8%)
$494.51 M(+1.9%)
Sep 2022
-
$485.41 M(-2.2%)
Jun 2022
-
$496.37 M(-21.1%)
Mar 2022
-
$629.44 M(+2.1%)
Dec 2021
$616.69 M(+56.1%)
$616.69 M(-0.8%)
Sep 2021
-
$621.46 M(+4.7%)
Jun 2021
-
$593.39 M(+55.0%)
Mar 2021
-
$382.73 M(-3.1%)
Dec 2020
$395.09 M(-24.7%)
$395.09 M(-13.5%)
Sep 2020
-
$456.80 M(+0.9%)
Jun 2020
-
$452.85 M(-6.7%)
Mar 2020
-
$485.33 M(-7.5%)
Dec 2019
$524.88 M(+26.0%)
$524.88 M(-5.3%)
Sep 2019
-
$554.21 M(+4.1%)
Jun 2019
-
$532.43 M(+8.4%)
Mar 2019
-
$491.36 M(+17.9%)
Dec 2018
$416.59 M(+85.1%)
$416.59 M(+14.3%)
Sep 2018
-
$364.40 M(+88.8%)
Jun 2018
-
$193.06 M(-1.5%)
Mar 2018
-
$196.01 M(-12.9%)
Dec 2017
$225.00 M(-28.6%)
$225.00 M(-35.1%)
Sep 2017
-
$346.48 M(+20.1%)
Jun 2017
-
$288.57 M(+1.9%)
Mar 2017
-
$283.12 M(-10.1%)
Dec 2016
$315.08 M(+55.5%)
$315.08 M(+52.5%)
Sep 2016
-
$206.56 M(-4.4%)
Jun 2016
-
$216.18 M(+17.0%)
Mar 2016
-
$184.82 M(-8.8%)
Dec 2015
$202.58 M(+517.1%)
$202.58 M(+13.5%)
Sep 2015
-
$178.51 M(+329.5%)
Jun 2015
-
$41.56 M(+33.0%)
Mar 2015
-
$31.26 M(-4.8%)
Dec 2014
$32.83 M(+27.4%)
$32.83 M(-0.9%)
Sep 2014
-
$33.14 M(+2.6%)
Jun 2014
-
$32.30 M(+2.6%)
Mar 2014
-
$31.46 M(+22.1%)
Dec 2013
$25.77 M
$25.77 M(+262.8%)
DateAnnualQuarterly
Sep 2013
-
$7.10 M(+251.8%)
Jun 2013
-
$2.02 M(+7.7%)
Mar 2013
-
$1.87 M(+220.8%)
Dec 2012
$584.20 K(+62.6%)
$584.20 K(+7.4%)
Sep 2012
-
$544.20 K(+30.9%)
Jun 2012
-
$415.70 K(+29.9%)
Mar 2012
-
$320.00 K(-10.9%)
Dec 2011
$359.30 K(-40.5%)
$359.30 K(-23.9%)
Sep 2011
-
$472.00 K(+11.1%)
Jun 2011
-
$425.00 K(-61.9%)
Mar 2011
-
$1.12 M(+84.8%)
Dec 2010
$604.00 K(+71.1%)
$604.00 K(+42.6%)
Sep 2010
-
$423.50 K(+83.3%)
Jun 2010
-
$231.10 K(+25.1%)
Mar 2010
-
$184.70 K(-47.7%)
Dec 2009
$353.10 K(+200.8%)
$353.10 K(+63.8%)
Sep 2009
-
$215.60 K(+467.4%)
Jun 2009
-
$38.00 K(-0.3%)
Mar 2009
-
$38.10 K(-67.5%)
Dec 2008
$117.40 K(+3457.6%)
$117.40 K(>+9900.0%)
Sep 2008
-
$200.00(>+9900.0%)
Jun 2008
-
$0.00(-100.0%)
Mar 2008
-
$11.70 K(+254.5%)
Dec 2007
$3300.00(-99.3%)
$3300.00(-17.5%)
Sep 2007
-
$4000.00(-75.8%)
Jun 2007
-
$16.50 K(-54.9%)
Mar 2007
-
$36.60 K(-92.2%)
Dec 2006
$471.80 K(+1351.7%)
$471.80 K(+1351.7%)
Sep 2006
-
$32.50 K(0.0%)
Jun 2006
-
$32.50 K(0.0%)
Mar 2006
-
$32.50 K(0.0%)
Dec 2005
$32.50 K(-90.5%)
$32.50 K(-90.5%)
Sep 2005
-
$341.10 K(+0.1%)
Jun 2005
-
$340.90 K(+0.1%)
Mar 2005
-
$340.70 K(+0.1%)
Dec 2004
$340.50 K(+0.2%)
$340.50 K(+0.1%)
Sep 2004
-
$340.30 K(+0.0%)
Jun 2004
-
$340.20 K(+0.1%)
Mar 2004
-
$340.00 K
Dec 2003
$339.80 K
-

FAQ

  • What is Sorrento Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Sorrento Therapeutics?
  • What is Sorrento Therapeutics annual total liabilities year-on-year change?
  • What is Sorrento Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Sorrento Therapeutics?
  • What is Sorrento Therapeutics quarterly total liabilities year-on-year change?

What is Sorrento Therapeutics annual total liabilities?

The current annual total liabilities of SRNE is $494.51 M

What is the all time high annual total liabilities for Sorrento Therapeutics?

Sorrento Therapeutics all-time high annual total liabilities is $616.69 M

What is Sorrento Therapeutics annual total liabilities year-on-year change?

Over the past year, SRNE annual total liabilities has changed by -$122.18 M (-19.81%)

What is Sorrento Therapeutics quarterly total liabilities?

The current quarterly total liabilities of SRNE is $654.65 M

What is the all time high quarterly total liabilities for Sorrento Therapeutics?

Sorrento Therapeutics all-time high quarterly total liabilities is $654.65 M

What is Sorrento Therapeutics quarterly total liabilities year-on-year change?

Over the past year, SRNE quarterly total liabilities has changed by +$67.17 M (+11.43%)